Furthermore, the inhibition of NF-κB attenuates pain and inhibits inflammation after peripheral nerve injury, suggesting that targeting the inflammatory response may be an effective approach in treating neuropathic pain [21]. The gene discussed is NFKB1; the disease is peripheral nerve injury.